Bio Pro Classes:

 
Thursday, 17 Dec 2015 - Wednesday, 13 Apr 2016
Category: Bio Pro Classes

 
Tuesday, 09 Feb 2016
Category: Bio Pro Classes

 
Wednesday, 10 Feb 2016
Category: Bio Pro Classes

 
Wednesday, 10 Feb 2016
Category: Bio Pro Classes

 
Tuesday, 16 Feb 2016 - Wednesday, 17 Feb 2016
Category: Bio Pro Classes

 
Tuesday, 23 Feb 2016 - Wednesday, 24 Feb 2016
Category: Bio Pro Classes

 
Thursday, 25 Feb 2016 - Friday, 26 Feb 2016
Category: Bio Pro Classes

 
Tuesday, 01 Mar 2016
Category: Bio Pro Classes

 
Wednesday, 02 Mar 2016
Category: Bio Pro Classes

 
Wednesday, 02 Mar 2016
Category: Bio Pro Classes

Event Registration Cart

Your cart is empty.

 

Oregon Bio Launches Search for Executive Director

            
Job description posted below

The Oregon Bioscience Association (Oregon Bio), Oregon's only trade association that advances the creation and advancement of biotechnology and the life sciences, has launched its Executive Director search.

Oregon Bio is the leading voice for Oregon's bioscience industry. Our mission is to cultivate a thriving bioscience ecosystem in Oregon. We achieve this mission through advocacy, member support, energizing business formation and expansion, targeted workforce training and networking. Our members include a broad range of organizations and entrepreneurs involved in research, commercialization and advanced manufacturing of life science technologies.

The successful candidate for this high-profile position will be well versed in the strategy and objectives needed to create ongoing economic opportunities for Oregon's 800-plus life science companies and service providers. These comprise device and pharmaceutical manufacturers, biotech firms, bio-agricultural and environmental firms, and channel vendors, as well as the state's universities, hospitals, and research institutions.

Oregon Bio’s board and community members serve on the search committee, which is tasked with identifying established, regional leaders with strengths in fiscal management and operations; regional economic development policy and advocacy; membership acquisition and maintenance; and program management. Inquiries and resumes can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it..

 Job Description

                    

News Release

JobPosting

Download PDF




EDNewsRelease

Download PDF

 _________________________________

News Flash

  • Brown announces grant support for small businesses, potentially boosting biotech

    Gov. Kate Brown says she wants small businesses to thrive in Oregon.

    As such, she's allocated $400,000 toward that end. The Small Business Innovation Research Grant Support Program will provide individual grants of $125,000 to four Oregon companies participating in a companion federal grant program, which is potentially good news for for bioscience startups.

    Several federal agencies, including the National Institutes of Health, provide grants to small businesses for research and development under the Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program.

    But those programs leave gaps, and earlier-stage companies are often courted by other states as they consider where to scale. The idea is to leverage federal dollars and prevent the flight of promising companies. SBIR/STTR matching grants are a tool used by 16 other states.

    "This support encourages more small businesses to stay and grow in Oregon," Brown said in a statement announcing the program.

    The Oregon Innovation Council will review applications and recommend award recipients. While they could come from a variety of realms, those in the biosciences would be likely candidates.

    In 2015, the National Institutes of Health awarded $17.5 million in SBIR grants to 24 Oregon companies (see below for a listing). Any company with a phase 2 grant could apply for the state funding. Those companies are past the phase of proving the science and are at the point of producing at commercialization plan, said Jennifer Fox, executive director of the Oregon Translational Research & Development Institute and the OTRADI Bioscience Incubator.

    “At a crucial time, that (funding) could make a big difference,” Fox said. “If you’re talking about building out your own space after you leave the incubator, it could be huge. More importantly, it’s that (the state is) listening to the needs of these companies.”

    Dennis McNannay, executive director of the Oregon Bioscience Association, said the state support is something he’s been advocating for over the past three years.

    “It’s great to see that first step, to get on that path,” McNannay said. “Obviously, we would like to see it grow. We know the demand and the need for these funds will grow. As more research begins to percolate out, the need will only get larger.”

    _________________________________

    Feb 2, 2016
    Elizabeth Hayes
    Staff Reporter
    Portland Business Journal

Bioscience News

  • The second day of #BIOCEO16 kicked off this morning with a look ahead to PDUFA VI and potential ways to improve the drug development and approval process. Moderated by BIO Executive Vice President of Emerging Companies Cartier Esham, the panelists included: Elizabeth Krutoholow, Analyst, Bloomberg Intelligence Jonathan Leff, Partner, Deerfield Management; Chairman, Deerfield Institute Richard F. Pops, Chairman & Chief Executive Officer, Alkermes The challenges and opportunities presented by the growing amount of available “real Read More >

  • Samuel Isaly, Managing Partner of OrbiMed Advisors, joined BIO CEO & Investor Conference attendees for a Fireside Chat, moderated by David Gluckman, Co-Head of the Global Healthcare Group at Lazard.  The discussion called upon Isaly’s wealth of healthcare and pharmaceutical knowledge spanning nearly 50 years, focusing on the value of innovation. OrbiMed has a simple “secret sauce” to their success, they only employ bright, hardworking, honest and lucky people to manage their funds.  As a Read More >

  • Jim Greenwood, President & CEO, Biotechnology Innovation Organization discusses the organizations new campaign, Time is Precious. Greenwood says, “… if we are going to continue to create new treatments and cures we are going to have to continue to invest and attract investment capital.”  Watch the full interview below.

joomla social media module

Underwriting Sponsors

Sustaining Sponsors

Principal Sponsors

Home | Bio in Oregon | BioPro Training | Events | Sponsors | Member Resources | News | About Us

Oregon Bioscience Association Copyright © 2016. All Rights Reserved.

javddt comicsbb.com